What does CUSIP G76279101 represent in this 13F holders report?

CUSIP G76279101 is the security identifier for ROIV - Roivant Sciences Ltd. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held ROIV - Roivant Sciences Ltd. - COMMON STOCK in Q3 2024?

291 institutional investors reported ROIV - Roivant Sciences Ltd. - COMMON STOCK for Q3 2024. Use the holders table for investor-level position and value details.

Roivant Sciences Ltd. - COMMON STOCK (ROIV)

CUSIP: G76279101

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / COMMON STOCK
Shares outstanding: 714,963,624
Total 13F shares: 569,136,749
Share change: +18,202,784
Total reported value: $6,567,461,922
Put/Call ratio: 199%
Price per share: $11.54
Number of holders: 291
Value change: +$223,573,966
Number of buys: 170
Number of sells: 122

Quarterly Holders Quick Answers

What is CUSIP G76279101?
CUSIP G76279101 identifies ROIV - Roivant Sciences Ltd. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2024
Previous quarter: Q2 2024

Recent filing periods for CUSIP G76279101:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of Roivant Sciences Ltd. - COMMON STOCK (ROIV) as of Q3 2024

As of 30 Sep 2024, Roivant Sciences Ltd. - COMMON STOCK (ROIV) was held by 291 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 569,136,749 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, QVT Financial LP, VIKING GLOBAL INVESTORS LP, FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, MORGAN STANLEY, Rubric Capital Management LP, STATE STREET CORP, and Patient Square Capital LP. This page lists 292 institutional shareholders reporting positions in this security for the Q3 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.